11
Predic’ng drug side effects with systems pharmacology John J Irwin October 2012 Mike Keiser Nick Hodge Brian Shoichet

Predicng*drug*side*effects*with* systems*pharmacology* · Predicng*drug*side*effects*with* systems*pharmacology* John*J*Irwin* October*2012* Mike%Keiser% Nick%Hodge% Brian%Shoichet%

Embed Size (px)

Citation preview

Predic'ng  drug  side  effects  with  systems  pharmacology  

John  J  Irwin  October  2012  

Mike  Keiser  Nick  Hodge  Brian  Shoichet  

Drugs  may  cause  unwanted  side  effects  nausea vomiting fatigue dizziness dry mouth headache itching muscle pains abdominal pain blurred vision constipation diarrhea loss of appetite memory loss failure to thrive palpitations problems with coordination ringing in the ears skin rashes or hives swelling of hands or feet heart attack syncope cafe-au-lait spots ecchymosis jaundice livedo reticularis necrolytic migratory erythema

heart attack

How  big  a  problem  are  we  talking  here?  9/30/04:  Merck  recalls  blockbuster  Vioxx  

Heart  aEack  and  stroke  

$  $   $   $  

$  

$  

$  

$  $  

$  

$  

$6  billion  in  claims  

MRK  vs  S&P  500  

Drug  development  failure  rates  are  rising  

II          III  

clinical  FAILURES   82%   50%  

by  phase:  

Arrowsmith,  J.  Nat  Rev  Drug  Disc  (Feb  &  May  2011).  

Efficacy  51%  

Strategic  29%  

Safety  19%  

Other  1%  

Cost  for  1  drug:  $0.8  billion  (2000)  vs.  $4-­‐12  billion  (2012)  

tA 3 Test the predictions

Z-score

Freq

uenc

y

drug vs. tA

drug vs. tB

Statistical model

1 For a drug,

tA

2 Compare it to new targets

… , tB

Predic\ng  side  effects  automa\cally  

»  

New  targets  for  

marketed  drugs  

a  Wired  top-­‐10  breakthrough  

of  2009  

Keiser,  Nat.  Biotech,  2007;  Keiser,  Nature,  2009;  Lounkine  &  Keiser,  Nature,  2012.  

culprit:  5-­‐HT2b  off-­‐target  

1997   heart  valve  disorder  

already  cost  Wyeth  

$21  billion  by  2004  

What  sorts  of  toxicity  could  we  predict?  

Off-­‐target   FenPhen  

1996  

Liver  (metabolic)  

Rezulin  (2000)  –  Parke  Davis  –  430+  pa\ents  suffered  liver  failures  

On-­‐target   Vioxx  (2004)  –  Merck  –  $6  billion  

Setola,  Roth  et  al,  Mol  Pharmacol.  2005,  68,  20-­‐23.  

CTX  inhibits  platelet  aggrega\on  in  human  

blood.  

We  use  the  networks  to  predict  side  effects  

Chlorotrianisene  (CTX)  is  a  synthe\c  

estrogen.  

Why  the  stomach  problems?  

Lounkine,  Keiser,  et  al.  Nature,  2012  

known  pharmacology  

new  predic\ons  

Similarity  Ensemble  Approach  

We  have  confirmed  

200+  

new  SEA  drug-­‐to-­‐target  predic\ons  

Keiser  &  Setola  et  al,  Nature,  2009.  Lounkine  &  Keiser  et  al,  Nature,  2012.  

This  is  a  challenge  we  can  best  solve  together  

Sept  2012  contract  

June  2012  Nature  paper  

Nov  2009  Nature  paper  

Brian  K.  Shoichet  lab  (founders)  

Rogers  Bridging-­‐the-­‐Gap  Awards  

2009,  2010,  &  2012  NIH  Grants  

QUESTIONS?  

 e  …  [email protected]  

w  …  seachangepharma.com